Oclacitinib

Rhodiola Rosea Extract, also known as Rhodiolaroseal P.E., is a standardised botanical extract derived from the adaptogenic plant Rhodiola rosea. It is commercially identified under CAS 97404-52-9 and EC 306-819-2, and is supplied as a concentrated plant extract for use across pharmaceutical, nutraceutical, and cosmetic applications.

In pharmaceutical and nutraceutical formulations, Rhodiola Rosea Extract functions as an antioxidant by scavenging free radicals and reducing oxidative stress at the cellular level. In personal care products, it is incorporated into anti-ageing and skin-conditioning formulations where its polyphenolic constituents help stabilise active ingredients and support skin resilience against environmental stressors.

This extract is available in standardised grades aligned with supplier specifications for active marker compounds such as rosavins and salidroside. Procurement should confirm compliance with applicable REACH registration requirements and relevant pharmacopoeial standards. Packaging formats vary by supplier and order volume.